Research across Sleep Disorders, Intrinsic
Related studies from across the Sleep Disorders, Intrinsic family.
48 trials tracked for sleep apnea: 1 in phase 3 or 4.
Showing the 48 most-cited and recently-updated of 48 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Physical activity showed mixed results for sleep apnea outcomes. In one trial, changes in Epworth Sleepiness Scale score ranged from -2.62 to 0.43, and quality of life changes ranged from -0.33 to 1.24, with no significant differences reported 3.
A PAP adherence program significantly improved PAP adherence (2.16 vs 0.87, p=.0001) and daytime sleepiness (6.11 vs 7.59, p<0.001), but sleep quality was not significantly different (7.72 vs 8.01, p=0.378) 14.
The Apne-Scan DC1 device is a recent diagnostic tool for sleep apnea 2.
Supplemental oxygen is being investigated as a treatment for sleep apnea 1.
Atomoxetine is under investigation for sleep apnea 4.
AI synthesis of 6 cited trials, updated Jun 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Sleep Disorders, Intrinsic family.